Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics

(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel in London. This event offers a platform for pharma R&D and patient advocacy to discuss integrating patient involvement in clinical trials to improve efficiency, reduce risks, and advance medical development. Keynote speakers include patient advocates Harry Verbunt, Peter DiBiaso, and Temi Olonisakin, MD, alongside experts from Roche, Johnson & Johnson, Sanofi, and other leading companies. The conference will address topics such as patient-informed research, decentralized trials, and reducing patient burden in clinical studies. The event is co-produced with industry leaders and aims to foster collaboration to enhance patient engagement and representation in clinical development.

(PRESS RELEASE) NEW YORK, NY, United States, 11-Feb-2025 — /EuropaWire/ — The Conference Forum today announced the launch of the 9th annual Patients as Partners® Europe event, taking place on May 20-21, 2025 at Royal National Hotel in London, UK. The meeting offers an unparalleled opportunity to hear from pharma R&D and patient advocacy on how patient involvement gets done, how it can be truly integrated to reduce risk and inefficiencies, and how it can advance medicine development for all.

“Recognizing patients as experts on their conditions and enabling their voices to be heard more clearly and deeply ultimately leads to more successful clinical trials and better healthcare outcomes,” said 2025 co-chair and patient advocate, Alfred Samuels.

The 2025 keynotes and featured speakers include:

• Patient advocate Harry Verbunt on the impact a clinical trial had on his life post-cancer diagnosis with suggestions for greater trial access.
• Patient advocate Peter DiBiaso on how to put patients at the center of the clinical research enterprise.
• Patient advocate Temi Olonisakin, MD, on patient perspectives on vital support and preferences in clinical research.
• Roche’s Lea-Isabelle Proulx, PhD, on mastering protocol complexity to reduce patient burden.
• Johnson & Johnson Innovative Medicine’s Beyza Klein on embedding an end-to-end patient engagement and advocacy approach into a matrix organization.
• Sanofi’s Catherine Coulouvrat, MD, on utilizing patient experience data to assess tolerability of products.
• Chiesi Farmaceutici SpA’s Marisa Minetti on leveraging patient archetypes to help in the development of study protocols.
• Azafaros’ Gisela Linthorst on involving the patient community in early clinical trials despite limited resources.

Pharma companies presenting case studies include:

• AstraZeneca
• Boehringer-Ingelheim
• Chiesi Farmaceutici SpA
• GSK
• Johnson & Johnson Innovative Medicine
• Regeneron
• Roche
• Sanofi

“We are pleased to present a wide range of case studies from R&D on significant progress in partnering with patients to advance medicine development and to hear directly from patients on their experience in clinical trials,” said Valerie Bowling, Executive Director, Conference Forum.  

Key topics include:

• The future of patient-informed research
• Patient preferences and decentralized clinical trials
• Increasing representation in clinical trials
• The patient experience data landscape
• Turning patient insights into action
• Mapping and demonstrating value for patient engagement
• Patient burden-reducing solutions and technologies
• HTA/Regulatory requirements and patient engagement in drug development

About Patients as Partners® Europe:
Patients as Partners® Europe is co-produced with patients, the R&D industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement, access and diversity across the entire clinical development continuum. To learn more about Patients as Partners and access the full agenda, visit PatientsAsPartnersEU.com.

About the Conference Forum:
The Conference Forum is a life science industry research, conference development and marketing firm. The company brings the full spectrum of executives together to share ideas and information on how to advance efficient medicine development and delivery, patient access and inclusive representation. The firm produces trusted conferences, webinars, podcasts and digital editorial, and provides marketing services. To learn more, visit theconferenceforum.org.

Media contact:

Bre Bugbee-Barrett
The Conference Forum
bre@tcfllc.org

Website:

FAQs for Patients as Partners® Europe 2025

1. What is the Patients as Partners® Europe event?

The Patients as Partners® Europe event is an annual conference focused on advancing patient involvement in clinical trials. It brings together pharma R&D professionals, patient advocates, and other stakeholders to discuss strategies for integrating patients into the clinical development process and improving healthcare outcomes.

2. When and where will the event take place?

The event will be held on May 20-21, 2025, at the Royal National Hotel in London, UK.

3. Who can attend the event?

The event is open to professionals in pharma R&D, patient advocacy groups, government agencies, academia, non-profit organizations, and anyone interested in enhancing patient involvement in clinical development.

4. What are the main topics covered at the event?

Key topics include the future of patient-informed research, patient preferences, decentralized clinical trials, increasing trial representation, patient experience data, and reducing patient burden in trials.

5. Who are some of the keynote speakers?

Keynote speakers include patient advocates Harry Verbunt, Peter DiBiaso, and Temi Olonisakin, MD, alongside experts from companies like Roche, Johnson & Johnson, Sanofi, and others.

6. What companies are presenting case studies?

Case studies will be presented by companies such as AstraZeneca, Boehringer-Ingelheim, Chiesi Farmaceutici SpA, GSK, Johnson & Johnson Innovative Medicine, Regeneron, Roche, and Sanofi.

7. How can I register for the event?

Registration details and the full agenda are available on the Patients as Partners® Europe website at PatientsAsPartnersEU.com.

8. How does this event benefit pharmaceutical companies and patients?

The event provides an opportunity to learn from case studies and gain insights from patient experiences, helping companies enhance their clinical trials and develop more inclusive, patient-centered approaches to drug development.

9. Can I attend virtually?

Please check the official event website for information about virtual participation options.

10. Who can I contact for more information?

For more details, you can contact Bre Bugbee-Barrett at The Conference Forum via email at bre@tcfllc.org.

SOURCE: The Conference Forum